References
- Kashani K, Rosner M, Ostermann M. Creatinine: from physiology to clinical application. Eur J Intern Med. 2020;72:9–14.
- Xiong X, Liu D, He W, et al. Identification of gender-related metabolic disturbances in autism spectrum disorders using urinary metabolomics. Int J Biochem Cell Biol. 2019;115:105594.
- Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J. 2004;80(947):516–526.
- Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am. 2006;35(2):355–365.
- Gibson GR, Scott KP, Rastall RA, et al. Dietary prebiotics: current status and new definition. Food Science & Technology Bulletin Functional Foods. 2010;7(1):1–19.
- Drakoularakou A, Rastall R, Gibson G, et al. Functional foods for the gut: probiotics, prebiotics and synbiotics. Functional Foods. 2011;65:449–470.
- Zheng HJ, Guo J, Wang Q, et al. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021;61(4):577–598.
- Nakabayashi I, Nakamura M, Kawakami K, et al. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant. 2011;26(3):1094–1098.
- Koppe L, Pillon NJ, Vella RE, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol. 2013;24(1):88–99.
- Rossi M, Klein K, Johnson DW, et al. Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int J Nephrol. 2012;2012:673631.
- Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J. 2015;8(2):168–179.
- Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
- Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
- Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
- Firouzi S, Mohd-Yusof B, Majid H, et al. Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial. BMC Complement Altern Med. 2015;15:433.
- Dehghani H, Heidari F, Mozaffari-Khosravi H, et al. Synbiotic supplementations for azotemia in patients with chronic kidney disease: a randomized controlled trial. Iran J Kidney Dis. 2016;10(6):351–357.
- Rossi M, Johnson DW, Morrison M, et al. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol. 2016;11(2):223–231.
- Abbasi B, Ghiasvand R, Mirlohi M. Kidney function improvement by soy milk containing Lactobacillus plantarum A7 in type 2 diabetic patients with nephropathy: a Double-Blinded randomized controlled trial. Iran J Kidney Dis. 2017;11(1):36–43.
- Ebrahimi Z, Nasli-Esfahani E, Nadjarzade A, et al. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. J Diabetes Metab Disord. 2017;16:23.
- Harata G, Kumar H, He F, et al. Probiotics modulate gut microbiota and health status in japanese cedar pollinosis patients during the pollen season. Eur J Nutr. 2017;56(7):2245–2253.
- Tuncay P, Arpaci F, Doganay M, et al. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: a randomized controlled study among neuro-critical care patients. Clin Nutr ESPEN. 2018;25:26–36.
- Ramos CI, Armani RG, Canziani MEF, et al. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant. 2019;34(11):1876–1884.
- Romão da Silva LdF, de Oliveira Y, de Souza EL, et al. Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial. Food Funct. 2020;11(8):7152–7163.
- Cosola C, Rocchetti MT, di Bari I, et al. An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients. Toxins. 2021;13(5):334.
- Armani RG, Carvalho AB, Ramos CI, et al. Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial. Nephrol Dial Transplant. 2021;37(1):85–91.
- McFarlane C, Krishnasamy R, Stanton T, et al. Synbiotics easing renal failure by improving gut microbiology II (SYNERGY II): a feasibility randomized controlled trial. Nutrients. 2021;13(12):4481.
- Miranda Alatriste PV, Urbina Arronte R, Gomez Espinosa CO, et al. Effect of probiotics on human blood urea levels in patients with chronic renal failure. Nutr Hosp. 2014;29(3):582–590.
- Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83(6):1010–1016.
- Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83(2):308–315.
- Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
- Mafra D, Lobo JC, Barros AF, et al. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol. 2014;9(3):399–410.
- Sabatino A, Regolisti G, Brusasco I, et al. Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol Dial Transplant. 2015;30(6):924–933.
- Brosnan J, Brosnan M. Creatine metabolism and the urea cycle. Mol Genet Metab. 2010;100: s49–S52.
- Tao S, Tao S, Cheng Y, et al. Effects of probiotic supplements on the progression of chronic kidney disease: a meta-analysis. Nephrology (Carlton). 2019;24(11):1122–1130.
- Yang H-L, Feng P, Xu Y, et al. The role of dietary fiber supplementation in regulating uremic toxins in patients with chronic kidney disease: a Meta-Analysis of randomized controlled trials. J Ren Nutr. 2021;31(5):438–447.
- Liu J, Zhong J, Yang H, et al. Biotic supplements in patients with chronic kidney disease: meta-Analysis of randomized controlled trials. J Ren Nutr. 2022;32(1):10–21.
- Dai Y, Quan J, Xiong L, et al. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis. Ren Fail. 2022;44(1):862–880.